This is a marketing case study, study it, generate a marketing case study and answer the following questions. Study focuses on the solutionsAdobeprovided for the Royal Bank of Scotland.Their top challenges includedfostering a culture of data driven decision making, eliminating disjointed systems, and delivering digital experiences that are relevant and easy to use.

Adobe's approach resulted in a 20 percent increase in conversion, as well as improved internal communications, faster optimization, and a reduction of their content management footprint.Of course, a study about two corporations isn't very interesting on its own. The best case studies personify the protagonists, including the vendor and the client company, by having plenty of quotes peppered throughout the entire story.

Naturally, the business problem to be solved is the big, bad villain here, so you want the client (and preferably, your own team as well) to weigh in on that problem: How complex it is, what solving it would mean, and what not solving it would cost.

Then, as the situation turns around, testimonials become essential.

Naturally, the longest, most emphatic testimonial should come from the top decision maker. But you should aim to include a glowing quote from many different stakeholders - representing the full cast of "characters" who might be making consensus buying decisions around your solution.

Question 24 1. Is inhaled insulin a suitable substitute for injectable insulin? 2. Is there, or will there soon be, insulin in the form of a tablet? Question 25 What are the complications of insulin other than hypoglycaemia and injection? Question 26 I would like to know the processes that go into administering the Alberti's/modified Alberti's regime in patients with uncontrolled diabetes mellitus. Question 27 Is there any role for steroids in the management of resistant diabetes mellitus (daily insulin requirement exceeding 100 units/day)? Don't they make glycaemic control worse? Question 28 What is the importance of potassium chloride (KCl) in the treatment of a diabetic patient (pre-operative care)? The formula in the text is explained as 16 U of insulin10 mmol of KCl500 mL 10% glucose. Question 29 What is the cut-off point of daily albumin excretion above which a diabetic patient without hypertension should be given an angiotensin converting enzyme (ACE) inhibitor? Question 30 What is the urinary concentration or 24-hour urine albumin content above which angiotensin-converting enzyme (ACE) inhibitors should be started in diabetic patients? Does an albumin (in microgram)/creatinine (in milligrams) ratio above 30 in the morning sample indicate a need for this? Question 31 Do potassium channel activators such as nicorandil have any benefit in the treatment of a diabetic patient with cardiovascular complications? Question 32 Is a dosage of 2.5 mg/day of methyltestosterone, as a component in some multivitamin formulae, safe to give to diabetics or will it make the diabetes more difficult to control (see also Chapter 5, question 5)? Question 33 How does diabetes mellitus cause atherosclerosis? Question 34 How does diabetes cause renal damage, especially diabetic nephropathy with the presence of microalbuminuria? Question 35 Type 1 diabetes causes nephropathy in 40% of cases and type 2 causes it in 20% of cases but the most common cause of nephropathy we see is type 2, why? Question 36 Why is intractable vomiting seen in diabetes mellitus and how can it be managed?